Inositide-specific phospholipase c β1 gene deletion in the progression of myelodysplastic syndrome to acute myeloid leukemia

Leukemia

Volumn 18, Issue 6, 2004, Pages 1122-1126

  Lo Vasco, V R ^a   Galabrese, G ^b   Manzoli, L ^a   Palka, G ^b   Spadano, A ^c   Morizio, E ^b   Guanciali Franchi, P ^b   Fantasia, D ^b   Cocco, L ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c Pescara General Hospital   (Italy)

Author keywords

Acute myeloid leukemia; Myelodysplastic syndrome; Phospholipase C 1

Indexed keywords

INOSITIDE SPECIFIC PHOSPHOLIPASE C BETA1; PHOSPHOLIPASE C; UNCLASSIFIED DRUG; ISOENZYME; PHOSPHATIDYLINOSITOL; PHOSPHOLIPASE C BETA;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ALLELE; ANALYTIC METHOD; ARTICLE; CANCER GROWTH; CELL CYCLE; CHROMOSOME 20P; CHROMOSOME PAINTING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE LOCATION; GENETIC CODE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; INTERSTITIUM; KARYOTYPE; MALE; MOLECULAR PROBE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ACUTE DISEASE; GENETICS; METABOLISM; MIDDLE AGED; MYELOID LEUKEMIA; PATHOLOGY; RISK FACTOR;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; GENE DELETION; HUMANS; ISOENZYMES; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PHOSPHATIDYLINOSITOLS; PHOSPHOLIPASE C; RISK FACTORS;

EID: 2942666283     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403368     Document Type: Article

References (24)

1. Silverman LR. Myelodysplastic syndrome. In: Bast RC, Kufe DW, Pollock RE, Weichselbaum RR, Holland JF, Frei E (eds). Cancer Medicine, 5th edn. Hamilton (Canada): BC Decker Inc. Publ., 2000, pp. 123.
2. Zeidman A, Dayan DB, Mittelman M. Secondary myelodysplastic syndromes and acute leukemias. Haematologia 1995; 27: 23-28.
3. Mrózek K, Heinonen K, de la Chapelle A, Bloomfield CD. Clinical significance of cytogenetics in acute myeloid leukemia. Semin Oncol 1997; 24: 17-31.
4. Bloomfield CD, Shuma C, Regal L. Long-term survival of patients with acute myeloid leukemia. A third follow-up of the Fourth International Workshop on Chromosomes in Leukemia. Cancer 1997; 80 (Suppl): 2191-2198.
5. Caligiuri MA, Bloomfield CD. The molecular biology of leukemia. In: DeVita Jr VT, Hellman S, Rosenberg SA (eds). Cancer: Principles & Practice of Oncology, 6th edn. Philadelphia, PA: Lippincott-Raven, 2000, pp. 2389-2404.
6. Sheikhha MH, Awan A, Tobal K, Liu Yin JA. Prognostic significance of FLT3 ITD and D835 mutations in AML patients. Hematol J 2003; 4: 41-46.
7. Peruzzi D, Aluigi M, Manzoli L, Billi AM, Di Giorgio FP, Morleo M et al. Molecular characterization of the human PLCβ1 gene. Biochim Biophys Acta 2002; 1584: 46-54.
8. Martelli AM, Manzoli L, Faenza I, Bortul R, Billi A, Cocco L. Nuclear inositol lipid signaling and its potential involvement in malignant transformation. Biochim Biophys Acta (Rev. Cancer) 2002; 1603: 10-16.
9. Peruzzi D, Calabrese G, Faenza I, Manzoli L, Matteucci A, Gianfrancesco F et al. Identification and chromosomal localisation by fluorescence in situ hybridisation of human gene of phosphoinositide-specific phospholipase Cβ1. Biochim Biophys Acta 2000; 484: 175-182.
10. Hu J, Jiang CC, Ng HK, Pang JC, Tong CY, Chen SQ. An allelotype study of primary and corresponding recurrent glioblastoma multiforme. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2003; 20: 56-58.
11. Gordon A, McManus A, Anderson J, Fisher C, Abe S, Nojima T et al. Chromosomal imbalances in pleomorphic rhabdomyosarcomas and identification of the alveolar rhabdomyosarcoma-associated PAX3-FOXO1A fusion gene in one case. Cancer Genet Cytogenet 2003; 140: 73-77.
12. Peng Z, Zhou C, Zhang F, Ling Y, Tang H, Bai S et al. Loss of heterozygosity of chromosome 20 in sporadic colorectal cancer. Chin Med J (Engl) 2002; 115: 1529-1532.
13. Wada N, Duh QY, Miura D, Brunaud L, Wong MG, Clark OH. Chromosomal aberrations by comparative genomic hybridization in hurthle cell thyroid carcinomas are associated with tumor recurrence. J Clin Endocrinol Metab 2002; 87: 4595-4601.
14. Le Beau MM. Cytogenetics Analysis of Hematological Malignant Diseases. In: Barch MJ (ed). The ACT Cytogenetics Laboratory Manual, Chapter 9, 2nd edn. New York, NY: Raven Press, 1991, pp. 395-449.
15. Schrock E, du Manoir S, Veldman T, Schoell B, Wienberg J, Ferguson-Smith MA et al. Multicolor spectral karyotyping of human chromosomes. Science 1996; 273: 494-497.
16. Calabrese G, Fantasia D, Spadano A, Morizio E, Di Bartolomeo P, Palka G. Karyotype refinement in five patients with acute myeloid leukemia using spectral karyotyping. Haematologica 2000; 85: 1219-1221.
17. Calabrese G, Sallese G, Stornaiuolo A, Morizio F, Palka G, De Blasi A. Assignment of the beta-arrestin 1 gene (ARRB1) to human chromosome 11q13. Genomics 1994; 23: 169-171.
18. Castro PD, Fairman J, Nagarajan L. The unexplored 5q13 locus: a role in hematopoietic malignancies. Leurk Lymphoma 1998; 30: 443-448.
19. Mori N, Morosetti R, Hoflehner E, Lubbert M, Mizoguchi H, Koeffler HP. Allelic loss in the progression of myelodysplastic syndrome. Cancer Res 2000; 60: 3039-3042.
20. Martelli AM, Gilmour RS, Bertagnolo V, Neri LM, Manzoli L, Cocco L. Nuclear localization and signalling activity of phosphoinositidase C beta in Swiss 3T3 cells. Nature 1992; 358: 242-245.
21. Cocco L, Martelli AM, Barnabei O, Manzoli FA. Nuclear inositol lipid signaling. Adv Enzyme Regul 2001; 41: 361-384.
22. Alvarez RA, Ghalayini AJ, Xu P, Hardcastle A, Bhattacharya S, Rao PN et al. cDNA sequence and gene locus of the human retinal phosphoinositide-specific phospholipase-C beta 4 (PLCB4). Genomics 1995; 29: 53-61.
23. Faenza I, Matteucci A, Manzoli L, Billi AM, Aluigi M, Peruzzi D et al. A role for nuclear phospholipase Cβ1 in cell cycle control. J Biol Chem 2000; 275: 30520-30524.
24. Faenza I, Bavelloni A, Fiume R, Lattanzi G, Maraldi NM, Gilmour RS et al. Up-regulation of nuclear PLCbeta1 in myogenic differentiation. J Cell Physiol 2003; 195: 446-452.